MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Ruth Gimeno
Ruth GimenoELI LILLY AND COMPANY

Ruth Gimeno

Vice President of Diabetes and Metabolic Research at ELI LILLY AND COMPANY

Manager

Deal Bio

Total Deals4
Valued Deals4
Total Value£ 2.46 B
Avg. Deal Size£ 616 M

Market Context

Sort

20 Nov 2020|United States|Biotechnology
Precision Biosciences
Eli Lilly And Company

Target: PRECISION BIOSCIENCES

Bidder: ELI LILLY AND COMPANY

3 Service Providers

1 Target | 2 Bidder

7 Dealmakers

1 Target | 7 Bidder

£ 25 M

Value

14 Jul 2021|United States|Biotechnology
Protomer Technologies
Eli Lilly And Company

Target: PROTOMER TECHNOLOGIES

Bidder: ELI LILLY AND COMPANY

5 Service Providers

3 Target | 2 Bidder

16 Dealmakers

6 Target | 10 Bidder

£ 722 M

Value

29 Jun 2023|United States|Biotechnology
Sigilon Therapeutics
Eli Lilly And Company

Target: SIGILON THERAPEUTICS INC

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

18 Dealmakers

14 Target | 4 Bidder

£ 244 M

Value

14 Jul 2023|United States|Biotechnology
VERSANIS
Eli Lilly And Company

Target: VERSANIS

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

26 Dealmakers

8 Target | 18 Bidder

£ 1.47 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite